Aspects of vertebrogenic pain syndrome

Abstract

Introduction: Back pain is a widespread problem, affecting a large part of the population. About 70% of the population suffers from recurrent back pain and about 15% of population of permanent form. The risk of recurrent back pain is very high (70-80%). 5 % of patients develop chronic back pain which lasts more then three months. Purpose and Objectives: Management evaluation of drug treatment in severe vertebrogenic pain syndrome through argumentation of administration of drugs with analgesic properties in medical practice in the country. Results: I conducted a retrospective study analyzing indication sheets of 58 patients diagnosed with vertebrogenic pain syndrome hospitalized in the Medical Department of the Ministry of Internal Affairs, during the period 2013-2014. Of the 58 patients aged 17-66 years, diagnosed with vertebral pathology with persistent, violent and chronic algyc syndrome, 32 were men (55,17 % ) and 26 (44,83 %) women. In most patients, examined according to indication sheets, the most frequently localization of pathologies with algyc syndrome was in the lumbar region constituting 41 patients (70.68%), the neck -11 patients (18.96%) and rarely found in the chest- six patients (10%.). According to the obtained results was determined that, in rural areas, vertebrogene pathologies predominated in men (41,37%) and in woman (18,9%); while in urban area results are reversed: women -25% and men -13.7%. Of the 58 patients analyzed, 20 were treated conservatively and 38 underwent surgery. I concluded that patients receiving conservative treatment most frequently were treated with the following drugs: tolperisone (midocalm) 16 patients, diazepam 13, clodifen 11 patients, 7 gabapentin, diclofenac 6 patients. The mentioned drugs have been prescribed for more then 7-10 days. Conclusion: - vertebrogenic pain syndrome incidence in urban area increases essentially among women and in rural areas vertebrogenic pathologies are more common among men. - Basic treatment of pain syndrome represent not only drugs with analgesic effect, also are used central muscle relaxants, tranquilizers and non-steroidal anti-inflammatory drugs. The treatment corresponds to national clinical protocol.